[1]
Yee, G. et al. 2025. Invasive Lobular Carcinoma Has Higher Immune Response Than Invasive Ductal Carcinoma in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers. World Journal of Oncology. (Sep. 2025). DOI:https://doi.org/10.14740/wjon2529.